Indeed, recent studies found that PON1 Q192R genotype and activity affect Hcy‐thiolactone levels in humans 49 and that among CAD patients undergoing percutaneous coronary intervention those with low serum HTase activity show significantly higher all‐cause mortality than patients with high HTase activity 50. This evidence concerns the gene PON1 and coronary artery disorder.